{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T23:10:33Z","timestamp":1790809833762,"version":"4.1.0"},"reference-count":185,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,1,27]],"date-time":"2022-01-27T00:00:00Z","timestamp":1643241600000},"content-version":"vor","delay-in-days":1974,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Advances in Nutrition"],"published-print":{"date-parts":[[2016,9]]},"DOI":"10.3945\/an.116.012187","type":"journal-article","created":{"date-parts":[[2016,9,15]],"date-time":"2016-09-15T12:43:46Z","timestamp":1473943426000},"page":"905-916","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":169,"title":["Omega-3 Polyunsaturated Fatty Acids and Oxylipins in Neuroinflammation and Management of Alzheimer Disease"],"prefix":"10.1016","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4004-7359","authenticated-orcid":false,"given":"Jessay Gopuran","family":"Devassy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shan","family":"Leng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa","family":"Gabbs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Md","family":"Monirujjaman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harold M","family":"Aukema","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.3945\/an.116.012187_bib1","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1111\/j.1742-4658.2010.07564.x","article-title":"Animal models of amyloid-beta-related pathologies in Alzheimer's disease","volume":"277","author":"Philipson","year":"2010","journal-title":"FEBS J"},{"key":"10.3945\/an.116.012187_bib2","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.jalz.2013.02.003","article-title":"2013 Alzheimer's disease facts and figures","volume":"9","author":"Thies","year":"2013","journal-title":"Alzheimers Dement"},{"key":"10.3945\/an.116.012187_bib3","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.jalz.2015.02.003","article-title":"2015 Alzheimer's disease facts and figures","volume":"11","author":"Alzheimer's Association","year":"2015","journal-title":"Alzheimers Dementi"},{"key":"10.3945\/an.116.012187_bib4","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1212\/WNL.0b013e31828726f5","article-title":"Alzheimer disease in the United States (2010\u20132050) estimated using the 2010 census","volume":"80","author":"Hebert","year":"2013","journal-title":"Neurology"},{"key":"10.3945\/an.116.012187_bib5","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.jalz.2010.11.007","article-title":"National estimates of the prevalence of Alzheimer's disease in the United States","volume":"7","author":"Brookmeyer","year":"2011","journal-title":"Alzheimers Dement"},{"key":"10.3945\/an.116.012187_bib6","first-page":"1","article-title":"Deaths: final data for 2010. National vital statistics reports- deaths: final data for 2010: from the Centers for Disease Control and Prevention, National Center for Health Statistics","volume":"61","author":"Murphy","year":"2013","journal-title":"Natl Vital Stat Rep"},{"key":"10.3945\/an.116.012187_bib7","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.jalz.2012.11.007","article-title":"The global prevalence of dementia: a systematic review and metaanalysis","volume":"9","author":"Prince","year":"2013","journal-title":"Alzheimers Dement"},{"key":"10.3945\/an.116.012187_bib8","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.cger.2014.04.001","article-title":"Dementia and cognitive impairment: epidemiology, diagnosis, and treatment","volume":"30","author":"Hugo","year":"2014","journal-title":"Clin Geriatr Med"},{"key":"10.3945\/an.116.012187_bib9","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1126\/science.8346443","article-title":"Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families","volume":"261","author":"Corder","year":"1993","journal-title":"Science"},{"key":"10.3945\/an.116.012187_bib10","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1001\/jama.1997.03550160069041","article-title":"Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease: a meta-analysis","volume":"278","author":"Farrer","year":"1997","journal-title":"JAMA"},{"key":"10.3945\/an.116.012187_bib11","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/S0140-6736(06)69113-7","article-title":"Alzheimer's disease","volume":"368","author":"Blennow","year":"2006","journal-title":"Lancet"},{"key":"10.3945\/an.116.012187_bib12","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1172\/JCI0216783","article-title":"Deciphering the genesis and fate of amyloid beta-protein yields novel therapies for Alzheimer disease","volume":"110","author":"Selkoe","year":"2002","journal-title":"J Clin Invest"},{"key":"10.3945\/an.116.012187_bib13","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/2047-9158-1-18","article-title":"Advances in the pathogenesis of Alzheimer's disease: a re-evaluation of amyloid cascade hypothesis","volume":"1","author":"Dong","year":"2012","journal-title":"Transl Neurodegener"},{"key":"10.3945\/an.116.012187_bib14","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1146\/annurev.ne.17.030194.002421","article-title":"Normal and abnormal biology of the beta-amyloid precursor protein","volume":"17","author":"Selkoe","year":"1994","journal-title":"Annu Rev Neurosci"},{"key":"10.3945\/an.116.012187_bib15","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.neuron.2005.04.008","article-title":"Presenilin-dependent transcriptional control of the Abeta-degrading enzyme neprilysin by intracellular domains of betaAPP and APLP","volume":"46","author":"Pardossi-Piquard","year":"2005","journal-title":"Neuron"},{"key":"10.3945\/an.116.012187_bib16","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1126\/science.1072994","article-title":"The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics","volume":"297","author":"Hardy","year":"2002","journal-title":"Science"},{"key":"10.3945\/an.116.012187_bib17","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1038\/nrn2168","article-title":"Intracellular amyloid-beta in Alzheimer's disease","volume":"8","author":"LaFerla","year":"2007","journal-title":"Nat Rev Neurosci"},{"key":"10.3945\/an.116.012187_bib18","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1126\/science.1566067","article-title":"Alzheimer's disease: the amyloid cascade hypothesis","volume":"256","author":"Hardy","year":"1992","journal-title":"Science"},{"key":"10.3945\/an.116.012187_bib19","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.bbadis.2004.08.014","article-title":"Tau, tangles, and Alzheimer's disease","volume":"1739","author":"Binder","year":"2005","journal-title":"Biochim Biophys Acta"},{"key":"10.3945\/an.116.012187_bib20","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.pharmthera.2012.07.001","article-title":"Tau as a therapeutic target in neurodegenerative disease","volume":"136","author":"Himmelstein","year":"2012","journal-title":"Pharmacol Ther"},{"key":"10.3945\/an.116.012187_bib21","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/S0896-6273(00)81127-7","article-title":"Age-dependent emergence and progression of a tauopathy in transgenic mice overexpressing the shortest human tau isoform","volume":"24","author":"Ishihara","year":"1999","journal-title":"Neuron"},{"key":"10.3945\/an.116.012187_bib22","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1111\/joim.12192","article-title":"Pathways to Alzheimer's disease","volume":"275","author":"Hardy","year":"2014","journal-title":"J Intern Med"},{"key":"10.3945\/an.116.012187_bib23","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0013950","article-title":"Genetic evidence implicates the immune system and cholesterol metabolism in the aetiology of Alzheimer's disease","volume":"5","author":"Jones","year":"2010","journal-title":"PLoS One"},{"key":"10.3945\/an.116.012187_bib24","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/j.neurobiolaging.2003.12.023","article-title":"ApoE genotype accounts for the vast majority of AD risk and AD pathology","volume":"25","author":"Raber","year":"2004","journal-title":"Neurobiol Aging"},{"key":"10.3945\/an.116.012187_bib25","doi-asserted-by":"crossref","first-page":"4985","DOI":"10.1523\/JNEUROSCI.5476-05.2006","article-title":"Profile and regulation of apolipoprotein E (ApoE) expression in the CNS in mice with targeting of green fluorescent protein gene to the ApoE locus","volume":"26","author":"Xu","year":"2006","journal-title":"J Neurosci"},{"key":"10.3945\/an.116.012187_bib26","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1021\/bi00507a059","article-title":"Human very low-density lipoprotein apolipoprotein-E isoprotein polymorphism is explained by genetic-variation and posttranslational modification","volume":"20","author":"Zannis","year":"1981","journal-title":"Biochemistry"},{"key":"10.3945\/an.116.012187_bib27","doi-asserted-by":"crossref","first-page":"9077","DOI":"10.1016\/S0021-9258(19)52510-8","article-title":"Human-E apoprotein heterogeneity - cysteine-arginine interchanges in the amino-acid-sequence of the apo-E isoforms","volume":"256","author":"Weisgraber","year":"1981","journal-title":"J Biol Chem"},{"key":"10.3945\/an.116.012187_bib28","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1007\/s11882-013-0417-1","article-title":"Etiology and pathogenesis of late-onset Alzheimer's disease","volume":"14","author":"Balin","year":"2014","journal-title":"Curr Allergy Asthma Rep"},{"key":"10.3945\/an.116.012187_bib29","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/0006-8993(91)91092-F","article-title":"Apolipoprotein E immunoreactivity in cerebral amyloid deposits and neurofibrillary tangles in Alzheimer's disease and kuru plaque amyloid in Creutzfeldt-Jakob disease","volume":"541","author":"Namba","year":"1991","journal-title":"Brain Res"},{"key":"10.3945\/an.116.012187_bib30","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/j.neuron.2014.01.045","article-title":"ApoE and Abeta in Alzheimer's disease: accidental encounters or partners?","volume":"81","author":"Kanekiyo","year":"2014","journal-title":"Neuron"},{"key":"10.3945\/an.116.012187_bib31","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1146\/annurev.genom.1.1.507","article-title":"Far more than a lipid transport protein","volume":"1","author":"Mahley","year":"2000","journal-title":"Annu Rev Genomomics Hum Genet"},{"key":"10.3945\/an.116.012187_bib32","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1016\/S0022-2275(20)42621-5","article-title":"Apolipoprotein E distribution among human plasma lipoproteins: role of the cysteine-arginine interchange at residue 112","volume":"31","author":"Weisgraber","year":"1990","journal-title":"J Lipid Res"},{"key":"10.3945\/an.116.012187_bib33","doi-asserted-by":"crossref","first-page":"5914","DOI":"10.1074\/jbc.M112.442103","article-title":"Levels of soluble apolipoprotein E\/amyloid-beta (Abeta) complex are reduced and oligomeric Abeta increased with APOE4 and Alzheimer disease in a transgenic mouse model and human samples","volume":"288","author":"Tai","year":"2013","journal-title":"J Biol Chem"},{"key":"10.3945\/an.116.012187_bib34","doi-asserted-by":"crossref","first-page":"2892","DOI":"10.1073\/pnas.050004797","article-title":"Apolipoprotein E isoform-dependent amyloid deposition and neuritic degeneration in a mouse model of Alzheimer's disease","volume":"97","author":"Holtzman","year":"2000","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.3945\/an.116.012187_bib35","doi-asserted-by":"crossref","first-page":"15181","DOI":"10.1523\/JNEUROSCI.1542-12.2012","article-title":"Apolipoprotein E, especially apolipoprotein E4, increases the oligomerization of amyloid beta peptide","volume":"32","author":"Hashimoto","year":"2012","journal-title":"J Neurosci"},{"key":"10.3945\/an.116.012187_bib36","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1055\/s-0033-1359319","article-title":"Alzheimer's disease","volume":"33","author":"Oboudiyat","year":"2013","journal-title":"Semin Neurol"},{"key":"10.3945\/an.116.012187_bib37","article-title":"Alzheimer's disease and the amyloid cascade hypothesis: a critical review","volume":"2012","author":"Reitz","year":"2012","journal-title":"Int J Alzheimers Dis"},{"key":"10.3945\/an.116.012187_bib38","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1212\/01.WNL.0000159740.16984.3C","article-title":"Clinical effects of Abeta immunization (AN1792) in patients with AD in an interrupted trial","volume":"64","author":"Gilman","year":"2005","journal-title":"Neurology"},{"key":"10.3945\/an.116.012187_bib39","doi-asserted-by":"crossref","first-page":"144","DOI":"10.2174\/156720509787602852","article-title":"Long-term follow-up of patients immunized with AN1792: reduced functional decline in antibody responders","volume":"6","author":"Vellas","year":"2009","journal-title":"Curr Alzheimer Res"},{"key":"10.3945\/an.116.012187_bib40","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.1212\/WNL.0b013e3181c67808","article-title":"A phase 2 multiple ascending dose trial of bapineuzumab in mild to moderate Alzheimer disease","volume":"73","author":"Salloway","year":"2009","journal-title":"Neurology"},{"key":"10.3945\/an.116.012187_bib41","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1159\/000318845","article-title":"Rosiglitazone monotherapy in mild-to-moderate Alzheimer's disease: results from a randomized, double-blind, placebo-controlled phase III study","volume":"30","author":"Gold","year":"2010","journal-title":"Dement Geriatr Cogn Disord"},{"key":"10.3945\/an.116.012187_bib42","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.2174\/156802611795860942","article-title":"Gamma-secretase inhibitors and modulators for the treatment of Alzheimer's disease: disappointments and hopes","volume":"11","author":"Imbimbo","year":"2011","journal-title":"Curr Top Med Chem"},{"key":"10.3945\/an.116.012187_bib43","first-page":"37","article-title":"EHT 0202: a neuroprotective and procognitive alpha-secretase stimulator targeted towards Alzheimer's disease therapy","volume":"15","author":"Desire","year":"2008","journal-title":"Eur J Neurol"},{"issue":"4, Suppl","key":"10.3945\/an.116.012187_bib44","first-page":"84","article-title":"The ADCS valproate neuroprotection trial: primary efficacy and safety results","volume":"5","author":"Tariot","year":"2009","journal-title":"Alzheimers Dement"},{"key":"10.3945\/an.116.012187_bib45","first-page":"942","article-title":"Divalproex sodium in nursing home residents with possible or probable Alzheimer Disease complicated by agitation: a randomized, controlled trial","volume":"13","author":"Tariot","year":"2005","journal-title":"Am J Geriatr Psychiatry"},{"key":"10.3945\/an.116.012187_bib46","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/S0197-4580(00)00124-X","article-title":"Inflammation and Alzheimer's disease","volume":"21","author":"Akiyama","year":"2000","journal-title":"Neurobiol Aging"},{"key":"10.3945\/an.116.012187_bib47","first-page":"1005","article-title":"Inflammation in Alzheimer disease: driving force, bystander or beneficial response?","volume":"12","author":"Wyss-Coray","year":"2006","journal-title":"Nat Med"},{"key":"10.3945\/an.116.012187_bib48","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.ijdevneu.2005.11.014","article-title":"Contribution of inflammatory processes to Alzheimer's disease: molecular mechanisms","volume":"24","author":"Sastre","year":"2006","journal-title":"Int J Dev Neurosci"},{"key":"10.3945\/an.116.012187_bib49","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.ijdevneu.2005.11.001","article-title":"Neuroinflammation and regeneration in the early stages of Alzheimer's disease pathology","volume":"24","author":"Hoozemans","year":"2006","journal-title":"Int J Dev Neurosci"},{"key":"10.3945\/an.116.012187_bib50","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.cca.2005.06.015","article-title":"Circulating biomarkers of cognitive decline and dementia","volume":"364","author":"Solfrizzi","year":"2006","journal-title":"Clin Chim Acta"},{"key":"10.3945\/an.116.012187_bib51","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/1742-2094-8-26","article-title":"Neurovascular dysfunction, inflammation and endothelial activation: implications for the pathogenesis of Alzheimer's disease","volume":"8","author":"Grammas","year":"2011","journal-title":"J Neuroinflammation"},{"key":"10.3945\/an.116.012187_bib52","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/S0197-4580(01)00276-7","article-title":"Inflammatory factors are elevated in brain microvessels in Alzheimer's disease","volume":"22","author":"Grammas","year":"2001","journal-title":"Neurobiol Aging"},{"key":"10.3945\/an.116.012187_bib53","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/0022-510X(91)90202-I","article-title":"Expression of intercellular adhesion molecule 1 (ICAM-1) in Alzheimer's disease","volume":"106","author":"Frohman","year":"1991","journal-title":"J Neurol Sci"},{"key":"10.3945\/an.116.012187_bib54","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1006\/bbrc.1994.2716","article-title":"Nitric-oxide synthase activity is elevated in brain microvessels in alzheimers-disease","volume":"205","author":"Dorheim","year":"1994","journal-title":"Biochem Biophys Res Commun"},{"key":"10.3945\/an.116.012187_bib55","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1016\/S0002-9440(10)61105-4","article-title":"Cerebrovascular transforming growth factor-beta contributes to inflammation in the Alzheimer's disease brain","volume":"160","author":"Grammas","year":"2002","journal-title":"Am J Pathol"},{"key":"10.3945\/an.116.012187_bib56","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.plefa.2012.05.008","article-title":"n-3 Polyunsaturated fatty acids in animal models with neuroinflammation","volume":"88","author":"Orr","year":"2013","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"key":"10.3945\/an.116.012187_bib57","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1038\/nm.2965","article-title":"Inhibition of IL-12\/IL-23 signaling reduces Alzheimer's disease-like pathology and cognitive decline","volume":"18","author":"Vom Berg","year":"2012","journal-title":"Nat Med"},{"key":"10.3945\/an.116.012187_bib58","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.jalz.2010.12.014","article-title":"Extended results of the Alzheimer's disease anti-inflammatory prevention trial","volume":"7","author":"Breitner","year":"2011","journal-title":"Alzheimers Dement"},{"key":"10.3945\/an.116.012187_bib59","doi-asserted-by":"crossref","first-page":"2238","DOI":"10.1038\/npp.2010.98","article-title":"Docosahexaenoic acid suppresses neuroinflammatory responses and induces heme oxygenase-1 expression in BV-2 microglia: implications of antidepressant effects for omega-3 fatty acids","volume":"35","author":"Lu","year":"2010","journal-title":"Neuropsychopharmacology"},{"key":"10.3945\/an.116.012187_bib60","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.intimp.2006.10.001","article-title":"Inhibitory effects of eicosapentaenoic acid on lipopolysaccharide-induced activation in BV2 microglia","volume":"7","author":"Moon","year":"2007","journal-title":"Int Immunopharmacol"},{"key":"10.3945\/an.116.012187_bib61","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1111\/j.1471-4159.2007.05129.x","article-title":"Docosahexaenoic acid prevents lipopolysaccharide-induced cytokine production in microglial cells by inhibiting lipopolysaccharide receptor presentation but not its membrane subdomain localization","volume":"105","author":"De Smedt-Peyrusse","year":"2008","journal-title":"J Neurochem"},{"key":"10.3945\/an.116.012187_bib62","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.plefa.2008.07.002","article-title":"Eicosapentaenoic acid inhibits interleukin-6 production in interleukin-1beta-stimulated C6 glioma cells through peroxisome proliferator-activated receptor-gamma","volume":"79","author":"Kawashima","year":"2008","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"key":"10.3945\/an.116.012187_bib63","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/j.neurobiolaging.2006.04.006","article-title":"Eicosapentaenoic acid confers neuroprotection in the amyloid-beta challenged aged hippocampus","volume":"28","author":"Lynch","year":"2007","journal-title":"Neurobiol Aging"},{"key":"10.3945\/an.116.012187_bib64","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1111\/j.1471-4159.2007.04848.x","article-title":"Modulation of amyloid-beta-induced and age-associated changes in rat hippocampus by eicosapentaenoic acid","volume":"103","author":"Minogue","year":"2007","journal-title":"J Neurochem"},{"key":"10.3945\/an.116.012187_bib65","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.plefa.2003.12.014","article-title":"Eicosapentaenoic acid and gamma-linolenic acid increase hippocampal concentrations of IL-4 and IL-10 and abrogate lipopolysaccharide-induced inhibition of long-term potentiation","volume":"70","author":"Kavanagh","year":"2004","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"key":"10.3945\/an.116.012187_bib66","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1111\/j.1471-4159.2004.02689.x","article-title":"Neuroprotective actions of eicosapentaenoic acid on lipopolysaccharide-induced dysfunction in rat hippocampus","volume":"91","author":"Lonergan","year":"2004","journal-title":"J Neurochem"},{"key":"10.3945\/an.116.012187_bib67","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1001\/jama.2009.2008","article-title":"Association of marine omega-3 fatty acid levels with telomeric aging in patients with coronary heart disease","volume":"303","author":"Farzaneh-Far","year":"2010","journal-title":"JAMA"},{"key":"10.3945\/an.116.012187_bib68","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1210\/jc.2005-1303","article-title":"Relationship of plasma polyunsaturated fatty acids to circulating inflammatory markers","volume":"91","author":"Ferrucci","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"10.3945\/an.116.012187_bib69","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/j.cca.2010.01.023","article-title":"Unsaturated fatty acids are inversely associated and n-6\/n-3 ratios are positively related to inflammation and coagulation markers in plasma of apparently healthy adults","volume":"411","author":"Kalogeropoulos","year":"2010","journal-title":"Clini Chim Acta"},{"key":"10.3945\/an.116.012187_bib70","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1177\/147323000903700619","article-title":"Effects of n-3 polyunsaturated fatty acid therapy on plasma inflammatory markers and N-terminal pro-brain natriuretic peptide in elderly patients with chronic heart failure","volume":"37","author":"Zhao","year":"2009","journal-title":"J Int Med Res"},{"key":"10.3945\/an.116.012187_bib71","doi-asserted-by":"crossref","first-page":"886","DOI":"10.3346\/jkms.2014.29.7.886","article-title":"Primary prevention of Alzheimer's disease: is it an attainable goal?","volume":"29","author":"Han","year":"2014","journal-title":"J Korean Med Sci"},{"key":"10.3945\/an.116.012187_bib72","first-page":"699","article-title":"Dementia (including Alzheimer's disease) can be prevented: statement supported by international experts","volume":"38","author":"Smith","year":"2014","journal-title":"J Alzheimers Dis"},{"key":"10.3945\/an.116.012187_bib73","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1001\/archpsyc.63.2.168","article-title":"Role of genes and environments for explaining Alzheimer disease","volume":"63","author":"Gatz","year":"2006","journal-title":"Arch Gen Psychiatry"},{"key":"10.3945\/an.116.012187_bib74","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1016\/S0197-4580(03)00008-3","article-title":"90-Year-old monozygotic female twin pair discordant for Alzheimer's disease","volume":"24","author":"J\u00e4rvenp\u00e4\u00e4","year":"2003","journal-title":"Neurobiol Aging"},{"key":"10.3945\/an.116.012187_bib75","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1212\/WNL.41.10.1549","article-title":"Discordance and concordance of dementia of the Alzheimer type (Dat) in monozygotic twins indicate heritable and sporadic forms of Alzheimers-disease","volume":"41","author":"Rapoport","year":"1991","journal-title":"Neurology"},{"key":"10.3945\/an.116.012187_bib76","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1002\/ana.410420514","article-title":"Dietary fat intake and the risk of incident dementia in the Rotterdam Study","volume":"42","author":"Kalmijn","year":"1997","journal-title":"Ann Neurol"},{"key":"10.3945\/an.116.012187_bib77","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1136\/bmj.325.7370.916","article-title":"Complications of diabetes in elderly people","volume":"325","author":"Gregg","year":"2002","journal-title":"BMJ"},{"key":"10.3945\/an.116.012187_bib78","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1001\/archneur.60.7.940","article-title":"Consumption of fish and n-3 fatty acids and risk of incident Alzheimer disease","volume":"60","author":"Morris","year":"2003","journal-title":"Arch Neurol"},{"key":"10.3945\/an.116.012187_bib79","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0163-7827(00)00017-5","article-title":"The essentiality of long chain n-3 fatty acids in relation to development and function of the brain and retina","volume":"40","author":"Lauritzen","year":"2001","journal-title":"Prog Lipid Res"},{"issue":"Suppl 2","key":"10.3945\/an.116.012187_bib80","doi-asserted-by":"crossref","first-page":"S74","DOI":"10.1016\/j.neurobiolaging.2014.03.033","article-title":"Dietary and lifestyle guidelines for the prevention of Alzheimer's disease","volume":"35","author":"Barnard","year":"2014","journal-title":"Neurobiol Aging"},{"key":"10.3945\/an.116.012187_bib81","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1212\/01.wnl.0000278116.37320.52","article-title":"Dietary patterns and risk of dementia: the Three-City cohort study","volume":"69","author":"Barberger-Gateau","year":"2007","journal-title":"Neurology"},{"key":"10.3945\/an.116.012187_bib82","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/0005-2760(96)00007-0","article-title":"Correlation between level of (n-3) polyunsaturated fatty acids in brain phospholipids and learning ability in rats: a multiple generation study","volume":"1300","author":"Jensen","year":"1996","journal-title":"Biochim Biophys Acta"},{"key":"10.3945\/an.116.012187_bib83","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1024\/0300-9831.70.5.251","article-title":"Effect of dietary docosahexaenoic acid and phosphatidylcholine on maze behavior and fatty acid composition of plasma and brain lipids in mice","volume":"70","author":"Lim","year":"2000","journal-title":"Int J Vitam Nutr Res"},{"key":"10.3945\/an.116.012187_bib84","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1212\/01.wnl.0000324268.45138.86","article-title":"Effect of fish oil on cognitive performance in older subjects: a randomized, controlled trial","volume":"71","author":"van de Rest","year":"2008","journal-title":"Neurology"},{"key":"10.3945\/an.116.012187_bib85","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1212\/01.WNL.0000103860.75218.A5","article-title":"Dietary intake of fatty acids and fish in relation to cognitive performance at middle age","volume":"62","author":"Kalmijn","year":"2004","journal-title":"Neurology"},{"key":"10.3945\/an.116.012187_bib86","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00394-013-0561-3","article-title":"Diet, cognition, and Alzheimer's disease: food for thought","volume":"53","author":"Otaegui-Arrazola","year":"2014","journal-title":"Eur J Nutr"},{"key":"10.3945\/an.116.012187_bib87","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1136\/bmj.325.7370.932","article-title":"Fish, meat, and risk of dementia: cohort study","volume":"325","author":"Barberger-Gateau","year":"2002","journal-title":"BMJ"},{"key":"10.3945\/an.116.012187_bib88","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1212\/01.wnl.0000183148.34197.2e","article-title":"Benefits of fatty fish on dementia risk are stronger for those without APOE epsilon4","volume":"65","author":"Huang","year":"2005","journal-title":"Neurology"},{"key":"10.3945\/an.116.012187_bib89","doi-asserted-by":"crossref","first-page":"170","DOI":"10.3945\/ajcn.2008.27037","article-title":"Dietary intake of fish and omega-3 fatty acids in relation to long-term dementia risk","volume":"90","author":"Devore","year":"2009","journal-title":"Am J Clin Nutr"},{"key":"10.3945\/an.116.012187_bib90","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1001\/archneur.62.12.noc50161","article-title":"Fish consumption and cognitive decline with age in a large community study","volume":"62","author":"Morris","year":"2005","journal-title":"Arch Neurol"},{"key":"10.3945\/an.116.012187_bib91","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1093\/ajcn\/85.4.1142","article-title":"Fish consumption, n\u20133 fatty acids, and subsequent 5-y cognitive decline in elderly men: the Zutphen Elderly Study","volume":"85","author":"van Gelder","year":"2007","journal-title":"Am J Clin Nutr"},{"key":"10.3945\/an.116.012187_bib92","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neubiorev.2014.11.008","article-title":"Omega-3 fatty acids intake and risks of dementia and Alzheimer's disease: a meta-analysis","volume":"48","author":"Wu","year":"2015","journal-title":"Neurosci Biobehav Rev"},{"key":"10.3945\/an.116.012187_bib93","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.jalz.2014.02.005","article-title":"Association of fish oil supplement use with preservation of brain volume and cognitive function","volume":"11","author":"Daiello","year":"2015","journal-title":"Alzheimers Dement"},{"key":"10.3945\/an.116.012187_bib94","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1093\/ajcn\/85.4.1103","article-title":"Plasma n\u20133 fatty acids and the risk of cognitive decline in older adults: the Atherosclerosis Risk in Communities Study","volume":"85","author":"Beydoun","year":"2007","journal-title":"Am J Clin Nutr"},{"key":"10.3945\/an.116.012187_bib95","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/j.jsbmb.2006.12.010","article-title":"An evaluation of the vitamin D3 content in fish: is the vitamin D content adequate to satisfy the dietary requirement for vitamin D?","volume":"103","author":"Lu","year":"2007","journal-title":"J Steroid Biochem Mol Biol"},{"key":"10.3945\/an.116.012187_bib96","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1212\/WNL.0000000000000755","article-title":"Vitamin D and the risk of dementia and Alzheimer disease","volume":"83","author":"Littlejohns","year":"2014","journal-title":"Neurology"},{"key":"10.3945\/an.116.012187_bib97","doi-asserted-by":"crossref","first-page":"313","DOI":"10.2147\/CIA.S13432","article-title":"The effect of phosphatidylserine-containing omega-3 fatty acids on memory abilities in subjects with subjective memory complaints: a pilot study","volume":"5","author":"Richter","year":"2010","journal-title":"Clin Interv Aging"},{"key":"10.3945\/an.116.012187_bib98","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1016\/j.pnpbp.2008.05.015","article-title":"The effects of omega-3 fatty acids monotherapy in Alzheimer's disease and mild cognitive impairment: a preliminary randomized double-blind placebo-controlled study","volume":"32","author":"Chiu","year":"2008","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.3945\/an.116.012187_bib99","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1001\/archneur.63.10.1402","article-title":"Omega-3 fatty acid treatment in 174 patients with mild to moderate Alzheimer disease. OmegAD study: a randomized double-blind trial","volume":"63","author":"Freund-Levi","year":"2006","journal-title":"Arch Neurol"},{"key":"10.3945\/an.116.012187_bib100","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1007\/BF02661403","article-title":"Fatty acid composition of oils from 21 species of marine fish freshwater fish + shellfish","volume":"41","author":"Gruger","year":"1964","journal-title":"J Am Oil Chem Soc"},{"key":"10.3945\/an.116.012187_bib101","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1001\/archneur.63.11.1545","article-title":"Plasma phosphatidylcholine docosahexaenoic acid content and risk of dementia and Alzheimer disease: the Framingham Heart Study","volume":"63","author":"Schaefer","year":"2006","journal-title":"Arch Neurol"},{"key":"10.3945\/an.116.012187_bib102","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1079\/BJN2002804","article-title":"Low serum cholesteryl ester-docosahexaenoic acid levels in Alzheimer's disease: a case-control study","volume":"89","author":"Tully","year":"2003","journal-title":"Br J Nutr"},{"key":"10.3945\/an.116.012187_bib103","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.jalz.2010.01.013","article-title":"Beneficial effects of docosahexaenoic acid on cognition in age-related cognitive decline","volume":"6","author":"Yurko-Mauro","year":"2010","journal-title":"Alzheimers Dement"},{"key":"10.3945\/an.116.012187_bib104","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.neures.2006.06.010","article-title":"Dietary supplementation of arachidonic and docosahexaenoic acids improves cognitive dysfunction","volume":"56","author":"Kotani","year":"2006","journal-title":"Neurosci Res"},{"key":"10.3945\/an.116.012187_bib105","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1001\/jama.2010.1510","article-title":"Docosahexaenoic acid supplementation and cognitive decline in Alzheimer disease: a randomized trial","volume":"304","author":"Quinn","year":"2010","journal-title":"JAMA"},{"key":"10.3945\/an.116.012187_bib106","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.plefa.2004.07.001","article-title":"Ethyl-EPA in Alzheimer's disease\u2014a pilot study","volume":"71","author":"Boston","year":"2004","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"key":"10.3945\/an.116.012187_bib107","doi-asserted-by":"crossref","first-page":"191","DOI":"10.3233\/JAD-2011-111217","article-title":"The effects of long-term omega-3 fatty acid supplementation on cognition and Alzheimer's pathology in animal models of Alzheimer's disease: a systematic review and meta-analysis","volume":"28","author":"Hooijmans","year":"2012","journal-title":"J Alzheimers Dis"},{"key":"10.3945\/an.116.012187_bib108","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.nbd.2015.09.002","article-title":"Dietary DHA supplementation in an APP\/PS1 transgenic rat model of AD reduces behavioral and Abeta pathology and modulates Abeta oligomerization","volume":"82","author":"Teng","year":"2015","journal-title":"Neurobiol Dis"},{"key":"10.3945\/an.116.012187_bib109","doi-asserted-by":"crossref","first-page":"149","DOI":"10.3233\/JAD-150341","article-title":"Arachidonic or docosahexaenoic acid diet prevents memory impairment in Tg2576 mice","volume":"48","author":"Hosono","year":"2015","journal-title":"J Alzheimers Dis"},{"key":"10.3945\/an.116.012187_bib110","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1016\/j.bbamem.2013.12.016","article-title":"Membrane lipid modifications and therapeutic effects mediated by hydroxydocosahexaenoic acid on Alzheimer's disease","volume":"1838","author":"Torres","year":"2014","journal-title":"Biochim Biophys Acta"},{"key":"10.3945\/an.116.012187_bib111","doi-asserted-by":"crossref","first-page":"7124","DOI":"10.1523\/JNEUROSCI.3439-13.2014","article-title":"Loss of MAP function leads to hippocampal synapse loss and deficits in the Morris water maze with aging","volume":"34","author":"Ma","year":"2014","journal-title":"J Neurosci"},{"key":"10.3945\/an.116.012187_bib112","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1007\/s10522-013-9461-4","article-title":"Cognitive recovery and restoration of cell proliferation in the dentate gyrus in the 5XFAD transgenic mice model of Alzheimer's disease following 2-hydroxy-DHA treatment","volume":"14","author":"Fiol-deRoque","year":"2013","journal-title":"Biogerontology"},{"key":"10.3945\/an.116.012187_bib113","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0036861","article-title":"Short-term long chain omega3 diet protects from neuroinflammatory processes and memory impairment in aged mice","volume":"7","author":"Labrousse","year":"2012","journal-title":"PLoS One"},{"key":"10.3945\/an.116.012187_bib114","doi-asserted-by":"crossref","first-page":"667","DOI":"10.3233\/JAD-2011-111265","article-title":"The isoform-specific pathological effects of apoE4 in vivo are prevented by a fish oil (DHA) diet and are modified by cholesterol","volume":"28","author":"Kariv-Inbal","year":"2012","journal-title":"J Alzheimers Dis"},{"key":"10.3945\/an.116.012187_bib115","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1039\/c1fo00002k","article-title":"Protective effects of prescription n-3 fatty acids against impairment of spatial cognitive learning ability in amyloid beta-infused rats","volume":"2","author":"Hashimoto","year":"2011","journal-title":"Food Funct"},{"key":"10.3945\/an.116.012187_bib116","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.bbi.2015.12.013","article-title":"Resolvin D1 and E1 promote resolution of inflammation in microglial cells in vitro","volume":"55","author":"Rey","year":"2016","journal-title":"Brain Behav Immun"},{"key":"10.3945\/an.116.012187_bib117","article-title":"Docosahexaenoic acid-derived neuroprotectin D1 induces neuronal survival via secretase- and PPARgamma-mediated mechanisms in Alzheimer's disease models","volume":"6","author":"Zhao","year":"2011","journal-title":"PLoS One"},{"key":"10.3945\/an.116.012187_bib118","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/j.jnutbio.2008.06.014","article-title":"Protective effect of docosahexaenoic acid against brain injury in ischemic rats","volume":"20","author":"Pan","year":"2009","journal-title":"J Nutr Biochem"},{"key":"10.3945\/an.116.012187_bib119","doi-asserted-by":"crossref","first-page":"2774","DOI":"10.1172\/JCI25420","article-title":"A role for docosahexaenoic acid-derived neuroprotectin D1 in neural cell survival and Alzheimer disease","volume":"115","author":"Lukiw","year":"2005","journal-title":"J Clin Invest"},{"key":"10.3945\/an.116.012187_bib120","doi-asserted-by":"crossref","first-page":"43807","DOI":"10.1074\/jbc.M305841200","article-title":"Novel docosanoids inhibit brain ischemia-reperfusion-mediated leukocyte infiltration and pro-inflammatory gene expression","volume":"278","author":"Marcheselli","year":"2003","journal-title":"J Biol Chem"},{"key":"10.3945\/an.116.012187_bib121","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1176\/appi.ajp.159.3.477","article-title":"Addition of omega-3 fatty acid to maintenance medication treatment for recurrent unipolar depressive disorder","volume":"159","author":"Nemets","year":"2002","journal-title":"Am J Psychiatry"},{"key":"10.3945\/an.116.012187_bib122","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1001\/archpsyc.59.10.913","article-title":"A dose-ranging study of the effects of ethyl-eicosapentaenoate in patients with ongoing depression despite apparently adequate treatment with standard drugs","volume":"59","author":"Peet","year":"2002","journal-title":"Arch Gen Psychiatry"},{"key":"10.3945\/an.116.012187_bib123","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1080\/07315724.2009.10719785","article-title":"EPA but not DHA appears to be responsible for the efficacy of omega-3 long chain polyunsaturated fatty acid supplementation in depression: evidence from a meta-analysis of randomized controlled trials","volume":"28","author":"Martins","year":"2009","journal-title":"J Am Coll Nutr"},{"key":"10.3945\/an.116.012187_bib124","doi-asserted-by":"crossref","first-page":"54","DOI":"10.4088\/JCP.14m08986","article-title":"A double-blind, randomized controlled clinical trial comparing eicosapentaenoic acid versus docosahexaenoic acid for depression","volume":"76","author":"Mischoulon","year":"2015","journal-title":"J Clin Psychiatry"},{"key":"10.3945\/an.116.012187_bib125","doi-asserted-by":"crossref","first-page":"913","DOI":"10.2174\/156720512803251147","article-title":"EPA and DHA differentially affect in vitro inflammatory cytokine release by peripheral blood mononuclear cells from Alzheimer's patients","volume":"9","author":"Serini","year":"2012","journal-title":"Curr Alzheimer Res"},{"key":"10.3945\/an.116.012187_bib126","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.clnu.2008.10.012","article-title":"Eicosapentaenoic acid is more effective than docosahexaenoic acid in inhibiting proinflammatory mediator production and transcription from LPS-induced human asthmatic alveolar macrophage cells","volume":"28","author":"Mickleborough","year":"2009","journal-title":"Clin Nutr"},{"key":"10.3945\/an.116.012187_bib127","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.nut.2007.11.005","article-title":"Dietary eicosapentaenoic acid and docosahexaenoic acid equally incorporate as decosahexaenoic acid but differ in inflammatory effects","volume":"24","author":"Sierra","year":"2008","journal-title":"Nutrition"},{"key":"10.3945\/an.116.012187_bib128","doi-asserted-by":"crossref","first-page":"34239","DOI":"10.1074\/jbc.M205289200","article-title":"Apoptotic changes in the aged brain are triggered by interleukin-1beta-induced activation of p38 and reversed by treatment with eicosapentaenoic acid","volume":"277","author":"Martin","year":"2002","journal-title":"J Biol Chem"},{"key":"10.3945\/an.116.012187_bib129","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1016\/S0899-9007(00)00392-0","article-title":"Eicosapentaenoic acid (EPA): an antiinflammatory omega-3 fat with potential clinical applications","volume":"16","author":"Babcock","year":"2000","journal-title":"Nutrition"},{"key":"10.3945\/an.116.012187_bib130","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.plefa.2010.02.006","article-title":"Polyunsaturated fatty acids, neuroinflammation and well being","volume":"82","author":"Lay\u00e9","year":"2010","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"key":"10.3945\/an.116.012187_bib131","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1212\/WNL.0b013e318264e394","article-title":"Plasma long-chain omega-3 fatty acids and atrophy of the medial temporal lobe","volume":"79","author":"Samieri","year":"2012","journal-title":"Neurology"},{"key":"10.3945\/an.116.012187_bib132","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/j.jnutbio.2008.08.009","article-title":"The protective effect of dietary eicosapentaenoic acid against impairment of spatial cognition learning ability in rats infused with amyloid beta(1\u201340)","volume":"20","author":"Hashimoto","year":"2009","journal-title":"J Nutr Biochem"},{"key":"10.3945\/an.116.012187_bib133","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0017397","article-title":"DHA improves cognition and prevents dysfunction of entorhinal cortex neurons in 3xTg-AD mice","volume":"6","author":"Arsenault","year":"2011","journal-title":"PLoS One"},{"key":"10.3945\/an.116.012187_bib134","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1002\/jnr.22266","article-title":"DHA diet reduces AD pathology in young APPswe\/PS1 Delta E9 transgenic mice: possible gender effects","volume":"88","author":"Perez","year":"2010","journal-title":"J Neurosci Res"},{"key":"10.3945\/an.116.012187_bib135","doi-asserted-by":"crossref","first-page":"558","DOI":"10.2174\/1568026615666150813144437","article-title":"Docosahexaenoic acid-phosphatidylcholine improves cognitive deficits in an Abeta23\u201335-induced Alzheimer's disease rat model","volume":"16","author":"Qu","year":"2016","journal-title":"Curr Top Med Chem"},{"key":"10.3945\/an.116.012187_bib136","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1051\/rnd:2004063","article-title":"Polyunsaturated fatty acids in the central nervous system: evolution of concepts and nutritional implications throughout life","volume":"44","author":"Alessandri","year":"2004","journal-title":"Reprod Nutr Dev"},{"key":"10.3945\/an.116.012187_bib137","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1111\/j.1750-3639.2005.tb00511.x","article-title":"The biochemistry of the isoprostane, neuroprostane, and isofuran Pathways of lipid peroxidation","volume":"15","author":"Roberts","year":"2005","journal-title":"Brain Pathol"},{"key":"10.3945\/an.116.012187_bib138","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.pharmthera.2009.01.004","article-title":"Comparative effects of DHA and EPA on cell function","volume":"122","author":"Gorj\u00e3o","year":"2009","journal-title":"Pharmacol Ther"},{"key":"10.3945\/an.116.012187_bib139","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1079\/PNS2005473","article-title":"Long-chain n-3 PUFA: plant v. marine sources","volume":"65","author":"Williams","year":"2006","journal-title":"Proc Nutr Soc"},{"key":"10.3945\/an.116.012187_bib140","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1111\/j.1471-4159.2008.05274.x","article-title":"Docosahexaenoic acid synthesis from n-3 fatty acid precursors in rat hippocampal neurons","volume":"105","author":"Kaduce","year":"2008","journal-title":"J Neurochem"},{"key":"10.3945\/an.116.012187_bib141","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s11745-007-3117-6","article-title":"Estradiol favors the formation of eicosapentaenoic acid (20: 5n-3) and n-3 docosapentaenoic acid (22: 5n-3) from alpha-linolenic acid (18: 3n-3) in SH-SY5Y neuroblastoma cells","volume":"43","author":"Alessandri","year":"2008","journal-title":"Lipids"},{"key":"10.3945\/an.116.012187_bib142","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1194\/jlr.M042275","article-title":"Whole body synthesis rates of DHA from alpha-linolenic acid are greater than brain DHA accretion and uptake rates in adult rats","volume":"55","author":"Domenichiello","year":"2014","journal-title":"J Lipid Res"},{"key":"10.3945\/an.116.012187_bib143","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1186\/1476-511X-13-97","article-title":"Providing male rats deficient in iron and n-3 fatty acids with iron and alpha-linolenic acid alone affects brain serotonin and cognition differently from combined provision","volume":"13","author":"Baumgartner","year":"2014","journal-title":"Lipids Health Dis"},{"key":"10.3945\/an.116.012187_bib144","first-page":"127","article-title":"Efficiency of conversion of alpha-linolenic acid to long chain n-3 fatty acids in man","volume":"5","author":"Brenna","year":"2002","journal-title":"Curr Opin Clin Nutr Metab Care"},{"key":"10.3945\/an.116.012187_bib145","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/S0741-5214(03)00473-7","article-title":"Linolenic acid prevents neuronal cell death and paraplegia after transient spinal cord ischemia in rats","volume":"38","author":"Lang-Lazdunski","year":"2003","journal-title":"J Vasc Surg"},{"key":"10.3945\/an.116.012187_bib146","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/S0022-2275(20)38713-7","article-title":"Effect of dietary alpha-linolenate\/linoleate balance on brain lipid compositions and learning ability of rats","volume":"28","author":"Yamamoto","year":"1987","journal-title":"J Lipid Res"},{"key":"10.3945\/an.116.012187_bib147","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1093\/emboj\/19.8.1784","article-title":"Polyunsaturated fatty acids are potent neuroprotectors","volume":"19","author":"Lauritzen","year":"2000","journal-title":"EMBO J"},{"key":"10.3945\/an.116.012187_bib148","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1161\/CIRCRESAHA.107.154443","article-title":"Polyunsaturated fatty acids are cerebral vasodilators via the TREK-1 potassium channel","volume":"101","author":"Blondeau","year":"2007","journal-title":"Circ Res"},{"key":"10.3945\/an.116.012187_bib149","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.phanu.2012.12.002","article-title":"Alpha-linolenic acid: a promising nutraceutical for the prevention of stroke","volume":"1","author":"Nguemeni","year":"2013","journal-title":"PharmaNutrition"},{"key":"10.3945\/an.116.012187_bib150","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.plefa.2007.10.021","article-title":"Omega-3 fatty acids and neurological injury","volume":"77","author":"Michael-Titus","year":"2007","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"key":"10.3945\/an.116.012187_bib151","doi-asserted-by":"crossref","first-page":"4672","DOI":"10.1523\/JNEUROSCI.5539-05.2006","article-title":"Omega-3 fatty acids improve recovery, whereas omega-6 fatty acids worsen outcome, after spinal cord injury in the adult rat","volume":"26","author":"King","year":"2006","journal-title":"J Neurosci"},{"key":"10.3945\/an.116.012187_bib152","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1006\/exnr.1996.0098","article-title":"Graded histological and locomotor outcomes after spinal cord contusion using the NYU weight-drop device versus transection","volume":"139","author":"Basso","year":"1996","journal-title":"Exp Neurol"},{"key":"10.3945\/an.116.012187_bib153","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1007\/s11064-014-1390-3","article-title":"Linolenic acid provides multi-cellular protective effects after photothrombotic cerebral ischemia in rats","volume":"39","author":"Liu","year":"2014","journal-title":"Neurochem Res"},{"key":"10.3945\/an.116.012187_bib154","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.freeradbiomed.2012.08.565","article-title":"Lipidomics of oxidized polyunsaturated fatty acids","volume":"59","author":"Massey","year":"2013","journal-title":"Free Radic Biol Med"},{"key":"10.3945\/an.116.012187_bib155","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.plipres.2007.12.004","article-title":"The opposing effects of n-3 and n-6 fatty acids","volume":"47","author":"Schmitz","year":"2008","journal-title":"Prog Lipid Res"},{"key":"10.3945\/an.116.012187_bib156","first-page":"136","article-title":"Omega-3 fatty acids, pro-inflammatory signaling and neuroprotection","volume":"10","author":"Bazan","year":"2007","journal-title":"Curr Opin Clin Nutr Metab Care"},{"key":"10.3945\/an.116.012187_bib157","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1111\/j.1365-2125.2012.04374.x","article-title":"Omega-3 polyunsaturated fatty acids and inflammatory processes: nutrition or pharmacology?","volume":"75","author":"Calder","year":"2013","journal-title":"Br J Clin Pharmacol"},{"key":"10.3945\/an.116.012187_bib158","doi-asserted-by":"crossref","first-page":"3912","DOI":"10.4049\/jimmunol.178.6.3912","article-title":"Resolvin E1 selectively interacts with leukotriene B4 receptor BLT1 and ChemR23 to regulate inflammation","volume":"178","author":"Arita","year":"2007","journal-title":"J Immunol"},{"key":"10.3945\/an.116.012187_bib159","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/prd.12034","article-title":"Natural resolution of inflammation","volume":"63","author":"Freire","year":"2013","journal-title":"Periodontol 2000"},{"issue":"1","key":"10.3945\/an.116.012187_bib160","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.jalz.2013.12.024","article-title":"Resolution of inflammation is altered in Alzheimer's disease","volume":"11","author":"Wang","year":"2014","journal-title":"Alzheimers Dement"},{"key":"10.3945\/an.116.012187_bib161","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1038\/89759","article-title":"Lipid mediator class switching during acute inflammation: signals in resolution","volume":"2","author":"Levy","year":"2001","journal-title":"Nat Immunol"},{"key":"10.3945\/an.116.012187_bib162","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/s11745-998-0193-y","article-title":"Eicosapentaenoic and docosahexaenoic acids alter rat spleen leukocyte fatty acid composition and prostaglandin E-2 production but have different effects on lymphocyte functions and cell-mediated immunity","volume":"33","author":"Peterson","year":"1998","journal-title":"Lipids"},{"key":"10.3945\/an.116.012187_bib163","first-page":"302","article-title":"n-3 Fatty acids and cysteinyl-leukotriene formation in humans in vitro, ex vivo, and in vivo","volume":"121","author":"von Schacky","year":"1993","journal-title":"J Lab Clin Med"},{"key":"10.3945\/an.116.012187_bib164","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1093\/ajcn\/83.2.331","article-title":"Dose-related effects of eicosapentaenoic acid on innate immune function in healthy humans: a comparison of young and older men","volume":"83","author":"Rees","year":"2006","journal-title":"Am J Clin Nutr"},{"key":"10.3945\/an.116.012187_bib165","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1016\/S0022-2275(20)41983-2","article-title":"Influence of dietary n-3 fatty acids on macrophage glycerophospholipid molecular species and peptidoleukotriene synthesis","volume":"32","author":"Chapkin","year":"1991","journal-title":"J Lipid Res"},{"key":"10.3945\/an.116.012187_bib166","doi-asserted-by":"crossref","first-page":"11276","DOI":"10.1073\/pnas.0601280103","article-title":"Transgenic mice rich in endogenous omega-3 fatty acids are protected from colitis","volume":"103","author":"Hudert","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.3945\/an.116.012187_bib167","doi-asserted-by":"crossref","first-page":"22254","DOI":"10.1074\/jbc.M703169200","article-title":"Enzymes and receptors of prostaglandin pathways with arachidonic acid-derived versus eicosapentaenoic acid-derived substrates and products","volume":"282","author":"Wada","year":"2007","journal-title":"J Biol Chem"},{"key":"10.3945\/an.116.012187_bib168","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1084\/jem.20020760","article-title":"Resolvins: a family of bioactive products of omega-3 fatty acid transformation circuits initiated by aspirin treatment that counter proinflammation signals","volume":"196","author":"Serhan","year":"2002","journal-title":"J Exp Med"},{"key":"10.3945\/an.116.012187_bib169","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/nri2294","article-title":"Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediators","volume":"8","author":"Serhan","year":"2008","journal-title":"Nat Rev Immunol"},{"key":"10.3945\/an.116.012187_bib170","doi-asserted-by":"crossref","first-page":"7671","DOI":"10.1073\/pnas.0409271102","article-title":"Resolvin E1, an endogenous lipid mediator derived from omega-3 eicosapentaenoic acid, protects against 2,4,6-trinitrobenzene sulfonic acid-induced colitis","volume":"102","author":"Arita","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.3945\/an.116.012187_bib171","doi-asserted-by":"crossref","first-page":"836","DOI":"10.4049\/jimmunol.0901809","article-title":"The anti-inflammatory and proresolving mediator resolvin E1 protects mice from bacterial pneumonia and acute lung injury","volume":"184","author":"Seki","year":"2010","journal-title":"J Immunol"},{"key":"10.3945\/an.116.012187_bib172","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1084\/jem.20042031","article-title":"Stereochemical assignment, antiinflammatory properties, and receptor for the omega-3 lipid mediator resolvin E1","volume":"201","author":"Arita","year":"2005","journal-title":"J Exp Med"},{"key":"10.3945\/an.116.012187_bib173","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1093\/carcin\/bgr049","article-title":"Suppressed liver tumorigenesis in fat-1 mice with elevated omega-3 fatty acids is associated with increased omega-3 derived lipid mediators and reduced TNF-alpha","volume":"32","author":"Weylandt","year":"2011","journal-title":"Carcinogenesis"},{"key":"10.3945\/an.116.012187_bib174","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1007\/BF00965154","article-title":"Inhibition by n-3 fatty acids of arachidonic acid metabolism in a primary culture of astroglial cells","volume":"19","author":"Petroni","year":"1994","journal-title":"Neurochem Res"},{"key":"10.3945\/an.116.012187_bib175","doi-asserted-by":"crossref","first-page":"14677","DOI":"10.1074\/jbc.M300218200","article-title":"Novel docosatrienes and 17S-resolvins generated from docosahexaenoic acid in murine brain, human blood, and glial cells. Autacoids in anti-inflammation","volume":"278","author":"Hong","year":"2003","journal-title":"J Biol Chem"},{"key":"10.3945\/an.116.012187_bib176","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s12975-010-0046-0","article-title":"Docosahexaenoic acid therapy of experimental ischemic stroke","volume":"2","author":"Belayev","year":"2011","journal-title":"Transl Stroke Res"},{"key":"10.3945\/an.116.012187_bib177","doi-asserted-by":"crossref","first-page":"3875","DOI":"10.1523\/JNEUROSCI.5529-08.2009","article-title":"Synthesis of lipoxin A4 by 5-lipoxygenase mediates PPARgamma-dependent, neuroprotective effects of rosiglitazone in experimental stroke","volume":"29","author":"Sobrado","year":"2009","journal-title":"J Neurosci"},{"key":"10.3945\/an.116.012187_bib178","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.expneurol.2012.04.007","article-title":"Novel aspirin-triggered neuroprotectin D1 attenuates cerebral ischemic injury after experimental stroke","volume":"236","author":"Bazan","year":"2012","journal-title":"Exp Neurol"},{"key":"10.3945\/an.116.012187_bib179","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.3945\/jn.109.119768","article-title":"An alpha-linolenic acid-rich formula reduces oxidative stress and inflammation by regulating NF-kappaB in rats with TNBS-induced colitis","volume":"140","author":"Hassan","year":"2010","journal-title":"J Nutr"},{"key":"10.3945\/an.116.012187_bib180","doi-asserted-by":"crossref","first-page":"2573","DOI":"10.1093\/eurheartj\/ehq501","article-title":"Dietary alpha-linolenic acid diminishes experimental atherogenesis and restricts T cell-driven inflammation","volume":"32","author":"Winnik","year":"2011","journal-title":"Eur Heart J"},{"key":"10.3945\/an.116.012187_bib181","doi-asserted-by":"crossref","first-page":"513","DOI":"10.3945\/an.114.007732","article-title":"Advances in our understanding of oxylipins derived from dietary PUFAs","volume":"6","author":"Gabbs","year":"2015","journal-title":"Adv Nutr"},{"key":"10.3945\/an.116.012187_bib182","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.exger.2014.04.005","article-title":"Elevated levels of pro-inflammatory oxylipins in older subjects are normalized by flaxseed consumption","volume":"59","author":"Caligiuri","year":"2014","journal-title":"Exp Gerontol"},{"key":"10.3945\/an.116.012187_bib183","first-page":"477","article-title":"Effects of the antirheumatic remedy hox alpha\u2014a new stinging nettle leaf extract\u2014on matrix metalloproteinases in human chondrocytes in vitro","volume":"17","author":"Schulze-Tanzil","year":"2002","journal-title":"Histol Histopathol"},{"key":"10.3945\/an.116.012187_bib184","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.3945\/jn.113.177360","article-title":"Dietary linoleic acid and alpha-linolenic acid differentially affect renal oxylipins and phospholipid fatty acids in diet-induced obese rats","volume":"143","author":"Caligiuri","year":"2013","journal-title":"J Nutr"},{"issue":"Suppl 2","key":"10.3945\/an.116.012187_bib185","doi-asserted-by":"crossref","first-page":"S79","DOI":"10.1016\/j.neurobiolaging.2014.02.029","article-title":"Nutrition and the brain: what advice should we give?","volume":"35","author":"Cooper","year":"2014","journal-title":"Neurobiol Aging"}],"container-title":["Advances in Nutrition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2161831322007773?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2161831322007773?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/academic.oup.com\/advances\/article-pdf\/7\/5\/905\/23754694\/an012187.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T01:05:38Z","timestamp":1761872738000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2161831322007773"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9]]},"references-count":185,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2016,9]]}},"alternative-id":["S2161831322007773"],"URL":"https:\/\/doi.org\/10.3945\/an.116.012187","relation":{},"ISSN":["2161-8313"],"issn-type":[{"value":"2161-8313","type":"print"}],"subject":[],"published":{"date-parts":[[2016,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Omega-3 Polyunsaturated Fatty Acids and Oxylipins in Neuroinflammation and Management of Alzheimer Disease","name":"articletitle","label":"Article Title"},{"value":"Advances in Nutrition","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.3945\/an.116.012187","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 American Society for Nutrition","name":"copyright","label":"Copyright"}]}}